BioMarin Pharmaceutical EVP Sells 2,318 Shares at $50.20

Cristin Hubbard, Executive Vice President and Chief Commercial Officer of BioMarin Pharmaceutical Inc., sold 2,318 shares of common stock on May 20, 2026, at a price of $50.20 per share. The transaction was executed as a "F" type transaction, which typically represents an open market sale. Following this sale, Hubbard now holds 42,472 shares of BioMarin common stock. The filing indicates the shares were held directly by the officer. This Form 4 filing was submitted on May 21, 2026, and signed by an attorney-in-fact on behalf of Hubbard. The transaction represents a routine insider trading activity by a corporate officer, providing transparency about stock ownership changes among company executives.